REV3L and neoplasm: Mice conditionally deleting Rev3l in a fraction of hematopoietic cells or in basal skin keratinocytes are viable, but exhibit enhanced tumor incidence, as a consequence of the chromosomal instability of Rev3l-null cells [7, 11].